Health: Genetics News

Today is March 19, 2024. All times in Eastern Daylight Time.

DNAnexus to Showcase the Power of High-Value Multi-Omics Data at the Precision Medicine in IBD Summit

03/18/2024 - 04:08 PM

BUSINESS WIRE
Global Liquid Biopsy Market Forecast Reveals a 15.2% CAGR Growth Through 2035 Amid Rising Demand for Non Invasive Cancer Diagnostics - ResearchAndMarkets.com

03/18/2024 - 09:10 AM

BUSINESS WIRE
Nodexus Names William Rhodes Executive Chairman of the Board

03/18/2024 - 09:01 AM

BUSINESS WIRE
Cellino Announces Ed Tekeian as Senior Vice President of Engineering

03/18/2024 - 09:00 AM

BUSINESS WIRE
Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS® T-cell Therapy

03/18/2024 - 08:02 AM

BUSINESS WIRE
seqWell Launches First Assay-ready, 384-well Library Preparation Kit to Enable Ultra-high Throughput Plasmid and Synthetic Construct Sequencing

03/18/2024 - 08:00 AM

BUSINESS WIRE
Inocras Inc. Unveils Rebranding of Genome Insight

03/18/2024 - 08:00 AM

BUSINESS WIRE
bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital

03/18/2024 - 08:00 AM

BUSINESS WIRE
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium

03/18/2024 - 08:00 AM

BUSINESS WIRE
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer

03/18/2024 - 07:00 AM

BUSINESS WIRE
Advanced Infusion Care (AIC) Now Offers Takeda’s GLASSIA® [Alpha1-Proteinase Inhibitor (Human)] and ARALAST® NP [Alpha1-Proteinase Inhibitor (Human)]

03/18/2024 - 06:12 AM

BUSINESS WIRE
New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older

03/15/2024 - 04:30 PM

BUSINESS WIRE
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

03/15/2024 - 04:15 PM

BUSINESS WIRE
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma

03/15/2024 - 03:15 PM

BUSINESS WIRE
Hannover Re US Partners with GalenusRx for Personalized, Precision Medication Safety Services

03/15/2024 - 09:00 AM

BUSINESS WIRE
Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research

03/15/2024 - 08:00 AM

BUSINESS WIRE
Sensorion Announces its Participation in the Annual Bioprocessing Summit Europe

03/15/2024 - 02:30 AM

BUSINESS WIRE
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration

03/14/2024 - 08:00 AM

BUSINESS WIRE
New KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease

03/14/2024 - 08:00 AM

BUSINESS WIRE
858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting

03/14/2024 - 08:00 AM

BUSINESS WIRE
Global gRNA Market to Surpass USD 1.62 Billion by 2030 with Robust Growth in Next-Generation Sequencing and Genome Engineering Applications - ResearchAndMarkets.com

03/14/2024 - 07:58 AM

BUSINESS WIRE
Satellos to Present at Upcoming Virtual Investor Conferences in March and April

03/14/2024 - 07:00 AM

BUSINESS WIRE
Alithea Genomics Closes CHF 2.8 Million in Seed Financing Extension Led by Novalis Biotech

03/14/2024 - 03:00 AM

BUSINESS WIRE
Sensorion Announces the Availability of its Financial Report for 2023

03/14/2024 - 02:35 AM

BUSINESS WIRE
Sensorion annonce la mise à disposition de son Rapport Financier Annuel 2023

03/14/2024 - 02:35 AM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10

Next »

Search